abstract |
Provided are specified 2-phenyl substituted imidazotriazinone compounds with a sarcosine functional group having improved non-specific binding and pharmacokinetic properties, as inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase. The compounds can be used for treating erectile dysfunction in a human or animal. |